Psychemedics Corporation

NASDAQ: PMD · Real-Time Price · USD
2.67
0.00 (0.00%)
At close: Jun 17, 2025, 10:00 PM

Psychemedics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
19.68M 22.1M 25.24M 24.91M
Cost of Revenue
12.58M 13.69M 15.95M 14.64M
Gross Profit
7.1M 8.41M 9.29M 10.26M
Operating Income
-1.89M -2.92M -1.08M -3.48M
Interest Income
n/a n/a n/a 49K
Pretax Income
-1.92M -3.44M -1.04M -821K
Net Income
-1.86M -4.15M -1.08M -665K
Selling & General & Admin
8.24M 10.19M 9.05M 8.93M
Research & Development
749K 1.14M 1.33M 1.13M
Other Expenses
n/a n/a 43K n/a
Operating Expenses
8.99M 11.33M 10.37M 10.05M
Interest Expense
26K 17K n/a 49K
Selling & Marketing Expenses
2.55M 3M 3.19M 2.8M
Cost & Expenses
21.58M 25.02M 26.32M 24.7M
Income Tax Expense
-55K 716K 44K -156K
Shares Outstanding (Basic)
5.87M 5.74M 5.63M 5.55M
Shares Outstanding (Diluted)
5.87M 5.74M 5.63M 5.55M
EPS (Basic)
-0.32 -0.72 -0.19 -0.12
EPS (Diluted)
-0.32 -0.72 -0.19 -0.12
EBITDA
191K -251K 2.23M 3.9M
EBIT
-1.89M -3.42M -1.08M 209K
Depreciation & Amortization
2.08M 2.67M 3.32M 3.69M